Evaluating 3D-Printed Pre-separator Inserts in a Fast Screening Impactor for Physicochemical Characterization of Fine Particle Dose Release from Dry Powder Inhalers.
Saved in:
| Title: | Evaluating 3D-Printed Pre-separator Inserts in a Fast Screening Impactor for Physicochemical Characterization of Fine Particle Dose Release from Dry Powder Inhalers. |
|---|---|
| Authors: | Reed NA; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA. Nathan.Reed@fda.hhs.gov., Dar R; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA., Holtgrewe N; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA., Cao LNY; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA., Liu X; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA., Conti DS; Office of Generic Drugs, Office of Research and Standards, Division of Therapeutic Performance-I, Food and Drug Administration, Silver Spring, Maryland, USA.; Office of Generic Drugs, Office of Safety and Clinical Evaluation, Division of Clinical Review, Food and Drug Administration, Silver Spring, Maryland, USA., Newman B; Office of Generic Drugs, Office of Research and Standards, Division of Therapeutic Performance-I, Food and Drug Administration, Silver Spring, Maryland, USA., Bielski E; Office of Generic Drugs, Office of Research and Standards, Division of Therapeutic Performance-I, Food and Drug Administration, Silver Spring, Maryland, USA., Rodriguez JD; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA., Guo C; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA. |
| Source: | AAPS PharmSciTech [AAPS PharmSciTech] 2025 Jul 30; Vol. 26 (7), pp. 205. Date of Electronic Publication: 2025 Jul 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40739372 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluating 3D-Printed Pre-separator Inserts in a Fast Screening Impactor for Physicochemical Characterization of Fine Particle Dose Release from Dry Powder Inhalers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reed+NA%22">Reed NA</searchLink>; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA. Nathan.Reed@fda.hhs.gov.<br /><searchLink fieldCode="AU" term="%22Dar+R%22">Dar R</searchLink>; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Holtgrewe+N%22">Holtgrewe N</searchLink>; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Cao+LNY%22">Cao LNY</searchLink>; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Conti+DS%22">Conti DS</searchLink>; Office of Generic Drugs, Office of Research and Standards, Division of Therapeutic Performance-I, Food and Drug Administration, Silver Spring, Maryland, USA.; Office of Generic Drugs, Office of Safety and Clinical Evaluation, Division of Clinical Review, Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Newman+B%22">Newman B</searchLink>; Office of Generic Drugs, Office of Research and Standards, Division of Therapeutic Performance-I, Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bielski+E%22">Bielski E</searchLink>; Office of Generic Drugs, Office of Research and Standards, Division of Therapeutic Performance-I, Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+JD%22">Rodriguez JD</searchLink>; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Guo+C%22">Guo C</searchLink>; Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, Division of Pharmaceutical Quality Research II, Food and Drug Administration, Saint Louis, Missouri, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100960111%22">AAPS PharmSciTech</searchLink> [AAPS PharmSciTech] 2025 Jul 30; Vol. 26 (7), pp. 205. <i>Date of Electronic Publication: </i>2025 Jul 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100960111 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1530-9932 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215309932%22">15309932 </searchLink><i>NLM ISO Abbreviation: </i>AAPS PharmSciTech <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40739372 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1208/s12249-025-03196-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 205 Titles: – TitleFull: Evaluating 3D-Printed Pre-separator Inserts in a Fast Screening Impactor for Physicochemical Characterization of Fine Particle Dose Release from Dry Powder Inhalers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reed NA – PersonEntity: Name: NameFull: Dar R – PersonEntity: Name: NameFull: Holtgrewe N – PersonEntity: Name: NameFull: Cao LNY – PersonEntity: Name: NameFull: Liu X – PersonEntity: Name: NameFull: Conti DS – PersonEntity: Name: NameFull: Newman B – PersonEntity: Name: NameFull: Bielski E – PersonEntity: Name: NameFull: Rodriguez JD – PersonEntity: Name: NameFull: Guo C IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 07 Text: 2025 Jul 30 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1530-9932 Numbering: – Type: volume Value: 26 – Type: issue Value: 7 Titles: – TitleFull: AAPS PharmSciTech Type: main |
| ResultId | 1 |
